FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway

AUTOR(ES)

Sahni, Malika

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

Several genetic forms of human dwarfism have been linked to activating mutations in FGF receptor 3, indicating that FGF signaling has a critical role in chondrocyte maturation and skeletal development. However, the mechanisms through which FGFs affect chondrocyte proliferation and differentiation remain poorly understood. We show here that activation of FGF signaling inhibits chondrocyte proliferation both in a rat chondrosarcoma (RCS) cell line and in primary murine chondrocytes. FGF treatment of RCS cells induces phosphorylation of STAT-1, its translocation to the nucleus, and an increase in the expression of the cell-cycle inhibitor p21WAF1/CIP1. We have used primary chondrocytes from STAT-1 knock-out mice to provide genetic evidence that STAT-1 function is required for the FGF mediated growth inhibition. Furthermore, FGF treatment of metatarsal rudiments from wild-type and STAT-1−/− murine embryos produces a drastic impairment of chondrocyte proliferation and bone development in wild-type, but not in STAT-1−/− rudiments. We propose that STAT-1 mediated down regulation of chondrocyte proliferation by FGF signaling is an homeostatic mechanism which ensures harmonious bone development and morphogenesis.

Documentos Relacionados

• Leucine restriction inhibits chondrocyte proliferation and differentiation through mechanisms both dependent and independent of mTOR signaling
• Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells
• FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression
• Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme
• IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway